NewGenIvf Group Limited Class A Ordinary Shares (NIVF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NewGenIvf Group Limited Class A Ordinary Shares (NIVF) has a cash flow conversion efficiency ratio of 4.973x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.35 Million) by net assets ($-1.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NIVF company net worth for the company's overall valuation and market capitalisation.
NewGenIvf Group Limited Class A Ordinary Shares - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NewGenIvf Group Limited Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NewGenIvf Group Limited Class A Ordinary Shares ranked by their cash flow conversion efficiency. Explore NewGenIvf Group Limited Class A Ordinary (NIVF) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Candela Invest SA
BR:CAND
|
0.050x |
|
Braille Energy Systems Inc
V:BES
|
-0.049x |
|
Lucapa Diamond Co Ltd
F:NHY
|
-0.007x |
|
Stinger Resources Inc
V:STNG
|
-0.044x |
|
Plaza Centers NV
WAR:PLZ
|
0.001x |
|
Clearside Biomedical Inc
NASDAQ:CLSD
|
0.102x |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
-0.686x |
|
Australian Bond Exchange Holdings Ltd
AU:ABE
|
0.350x |
Annual Cash Flow Conversion Efficiency for NewGenIvf Group Limited Class A Ordinary Shares (2021–2025)
The table below shows the annual cash flow conversion efficiency of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2025. View NewGenIvf Group Limited Class A Ordinary (NIVF) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $25.99 Million | $-10.93 Million | -0.420x | -107.54% |
| 2024-12-31 | $-1.48 Million | $-8.26 Million | 5.577x | +10245.75% |
| 2023-12-31 | $15.60 Million | $-857.36K | -0.055x | +98.95% |
| 2022-12-31 | $100.68K | $-527.12K | -5.235x | -234.26% |
| 2021-12-31 | $-914.91K | $1.43 Million | -1.566x | -- |
About NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screen… Read more